The Effect of Mobile Application Robot Developed for Pediatric Diabetes Management on Children With Diabetes Mellitus
NCT ID: NCT05333393
Last Updated: 2025-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2023-05-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Mobile Application on the Pediatric Diabetes Management
NCT05333185
The Effect Of Model-Based Dıgıtal Game On Metabolıc Control, Self-Effıcıency And Qualıty Of Lıfe In Chıldren Wıth Type 1 Dıabetes
NCT05923632
Motivational Interviewing and WhatsApp-Based Monitoring for Metabolic Control and Self-Efficacy in Adolescents With T1DM
NCT06635460
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
NCT04016987
The Effect of Kamishibai Diabetes Education on Knowledge, HbA1c, and Quality of Life in Children
NCT06535672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Children in the experimental group will be informed about the diabot application and how they will use the application to manage their disease processes. Children/adolescents in the study group and their parents will be evaluated 5 times, once every 3 months, through data collection tools. Data will be collected from the children/adolescents in the control group and their parents by means of pre-test and data collection tools 5 times, once every 3 months.
DİABOT (mobile application robot )
Thanks to the trainings given through the mobile application robot developed for pediatric diabetes management, it is aimed to have an effect on the quality of life, diabetes self-management and physiological parameter levels of children with Type 1 diabetes, and to easily obtain the information they need even when they cannot come to the outpatient clinic. In addition, thanks to the application robot, he will be able to create his own exercise program and determine his diet.
Control group
The control group will recieve standard diabetes treatment without any training intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DİABOT (mobile application robot )
Thanks to the trainings given through the mobile application robot developed for pediatric diabetes management, it is aimed to have an effect on the quality of life, diabetes self-management and physiological parameter levels of children with Type 1 diabetes, and to easily obtain the information they need even when they cannot come to the outpatient clinic. In addition, thanks to the application robot, he will be able to create his own exercise program and determine his diet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understanding and speaking Turkish
* No vision or hearing problems
* Having been diagnosed with Type 1 Diabetes Mellitus at least six months ago
* Parents and children must have an internet connection, computer, smartphone or tablet to use the Diabot application
Exclusion Criteria
* The children who will participate in the study have a neurological disease together with diabetes,
* No internet connection and no smartphone or tablet,
* Not having the ability to use the application.
7 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Necmettin Erbakan University
OTHER
Dokuz Eylul University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Murat Bektaş
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Murat BEKTAŞ, Prof. Dr.
Role: STUDY_DIRECTOR
Dokuz Eylül University Faculty of Nursing
Merve AŞKIN CERAN, PhD Student
Role: PRINCIPAL_INVESTIGATOR
Dokuz Eylül University Institute of Health Sciences
Beray SERVER EKLİOĞLU, Doç. Dr.
Role: PRINCIPAL_INVESTIGATOR
Necmettin Erbakan University Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Necmettin Erbakan University Medical Faculty Hospital
Konya, Meram, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.